Rioux-Leclercq Nathalie, Leray Emmanuelle, Patard Jean-Jacques, Lobel Bernard, Guillé François, Jouan Florence, Bellaud Pascale, Epstein Jonathan I
Département d'Anatomie et de Cytologie Pathologiques, Faculté de Médecine, Rennes, France.
Hum Pathol. 2005 May;36(5):531-5. doi: 10.1016/j.humpath.2005.01.021.
Cribriform and/or papillary prostatic lesions observed on limited tissue, such as needle biopsy, can pose diagnostic dilemmas. One such area of difficulty is the distinction between papillary and/or cribriform prostatic high-grade prostatic intraepithelial neoplasia (HG-PIN) and ductal adenocarcinoma. Over 48 months, we identified 17 cases of ductal adenocarcinoma and 17 cases of HG-PIN from radical retropubic prostatectomy specimens. The HG-PIN lesions were in all cases associated with an acinar prostatic adenocarcinoma component. For each case, we evaluated the proliferative activity, assessed by Ki-67 immunohistochemistry. The majority (82%) of ductal adenocarcinomas were composed of mixed papillary and cribriform patterns, with the remaining demonstrating pure papillary or cribriform patterns. The HG-PIN lesions showed a papillary, cribriform, or mixed papillary/cribriform architecture. The proliferative activity, defined as Ki-67 labeling index, was statistically higher in ductal adenocarcinoma (mean 33%, range 21%-66%) as compared with HG-PIN (mean 6%, range 2%-15%), with no overlap in the Ki-67 indices (P = 0001). A combination of histological features and measurements of cellular proliferation may be helpful to distinguish HG-PIN from ductal adenocarcinoma in limited prostatic tissue samples.
在有限的组织(如穿刺活检)中观察到的筛状和/或乳头状前列腺病变可能会带来诊断难题。其中一个难点在于区分乳头状和/或筛状前列腺高级别前列腺上皮内瘤变(HG-PIN)与导管腺癌。在48个月的时间里,我们从耻骨后前列腺根治性切除标本中识别出17例导管腺癌和17例HG-PIN。所有HG-PIN病变均与腺泡前列腺腺癌成分相关。对于每例病例,我们通过Ki-67免疫组化评估其增殖活性。大多数(82%)导管腺癌由乳头状和筛状混合模式组成,其余表现为单纯乳头状或筛状模式。HG-PIN病变呈现乳头状、筛状或乳头状/筛状混合结构。与HG-PIN(平均6%,范围2%-15%)相比,导管腺癌的增殖活性(定义为Ki-67标记指数)在统计学上更高(平均33%,范围21%-66%),Ki-67指数无重叠(P = 0.001)。组织学特征和细胞增殖测量相结合可能有助于在有限的前列腺组织样本中区分HG-PIN和导管腺癌。